Wednesday, September 28, 2016 6:32:34 PM
IF indeed, it is the case that with each effort NNVC is converging towards solutions on the scale-up problem and the ligand design issue, THEN there is hope. In other words, if your description is correct, then NNVC is in the process of solving a tractable optimization problem. This type of search problem can be solved by using what has been learned in prior steps to guide the next step of the search for a solution. Some engineering problems behave this way. However, other many problems don't behave this way. They require brute force searching - every possible solution must be tried. If the set of possibles is very large and each search step takes time and resources that exceed what is available they are essentially unsolvable.
The problem is this - at the outset, it is not known if the problem is tractable or not.
Given the time NNVC has already spent and their continual shifts from one virus to another without meaningful progress suggests to me that they are dealing with at least one, intractable problem. Maybe it's the scale-up issue. Maybe it's the ligand design issue. Maybe it's some entirely different issue.
I feel it's incumbent upon management to fully candid with shareholders about the technical hurdles they are facing. It was my hope that the CEO letter that never came would do this. So far this has been a disappointment.
Trendliner
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM